The Methylation Panel assesses the status of methylation by measuring metabolites in the blood plasma, to offer insight for patients with methylation-related conditions.
The Methylation Panel provides information into the status of methylation, combining biomarkers and genetic information to give greater insight than biomarkers alone.
Methylation plays an all-encompassing role in human physiology, meaning that defects in the process can have a wide range of effects. Methylation dysfunction is related to many conditions, including cancer, toxin exposure, psychiatric disorders and cardiovascular disease.
By identifying any defects in the methylation pathway, the Methylation Panel helps to identify the underlying problems in many conditions. As such, it helps to guide nutritional, supplemental and lifestyle interventions that support methylation and help clients regain optimal health.
This test requires a blood sample via a blood draw procedure, which must be performed by a doctor or phlebotomist.